Introduction: Because of recent progress in neuroendocrine tumor treatment (NET), more data are required about this pathology in France.
Aim(s): We designed a 1-year prospective epidemiological study to assess the characteristics of newly diagnosed NETs including pathological diagnosis.
Materials and methods: From August 2010 to July 2011, all pathology laboratories in France were invited to register all incident cases of gastroenteropancreatic (GEP) and thoracic NET, excluding small cell carcinoma.
Conference: 9th Annual ENETS Conference (2012)
Presenting Author: Dr Xavier Parot
To read results and conclusion, please login ...
Further abstracts you may be interested in